Clinical Trials Logo

Erythema clinical trials

View clinical trials related to Erythema.

Filter by:

NCT ID: NCT03853538 Completed - Erythema Clinical Trials

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering

Start date: January 28, 2019
Phase: Phase 4
Study type: Interventional

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery and reduction of skin redness after a dermatological procedure (non-ablative laser) on the face for treatment of fine wrinkles, scars, open pores and change of pigmentation. After the dermatological procedure, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.

NCT ID: NCT03852563 Completed - Erythema Clinical Trials

A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering

Start date: March 18, 2019
Phase: N/A
Study type: Interventional

In this study, researchers want to learn more about the effect of dexpanthenol cream on skin recovery and reduction of skin rash after a dermatological procedure (ablative laser) on the face for treatment of fine wrinkles, scars and open pores in adult women. After the dermatological procedure, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such as redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol cream.

NCT ID: NCT03811977 Completed - Dermis Density Clinical Trials

The Effect of 12-Week Dietary Intake of Lutein on Minimal Erythema Dose and Other Skin Parameters

VIST Lutein
Start date: March 4, 2019
Phase: N/A
Study type: Interventional

The double-center, randomized, placebo-controlled, one-period effectiveness study will include 30 subjects (women, aged between 25 to 55 years, Fitzpatrick phototype II and III). Subjects will be divided in two groups, 15 in each. One group (test group) will receive investigational product - lutein syrup (4 mg/mL; daily dose 20 mg) and the other (placebo group) placebo syrup. Participants will test continuous administration of placebo or investigational product for 12 weeks in order to demonstrate and assess multiple-dose effects. The primary objective is to assess the photoprotective potential of the investigational product in relation to placebo product. The secondary objectives are to assess effects of investigational product on dermis density and skin viscoelasticity after 12 weeks of dietary supplementation.

NCT ID: NCT03633877 Completed - Erythema Clinical Trials

Durapore vs. Hy-Tape to Secure The Endotracheal Tube

Start date: September 17, 2018
Phase: N/A
Study type: Interventional

While adhesive tape is commonly used to secure endotracheal tubes (ETT) during general anesthesia, its use is also associated with facial skin injuries. Although a variety of adhesive tapes are used in clinical practice, few studies have investigated the likelihood of adhesives in producing injury. The purpose of this randomized, controlled, non-inferiority study was to compare the proportion of facial skin injury with Duraporeā„¢ vs. Hy-Tape®.

NCT ID: NCT03584919 Completed - Clinical trials for Erythema Chronicum Migrans

Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans

Start date: June 1, 2006
Phase: N/A
Study type: Interventional

A European, prospective clinical trial in which doxycycline and cefuroxime axetil were compared in the treatment of adult patients with erythema migrans included a control group to address this question. Evaluations of patients were conducted at baseline, 14 days and 2, 6, and 12 months after enrollment. Control subjects were evaluated at baseline and at 6 and 12 months. Subjective complaints that newly developed or intensified since the onset of erythema migrans or since the date of enrollment for controls were referred to as "new or increased symptoms"(NOIS).

NCT ID: NCT03549429 Completed - Erythema Clinical Trials

Tegaderm vs. EyeGard for Eye Protection

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This study compares TegadermTM and EyeGard® in general anesthesia.

NCT ID: NCT03530787 Completed - Microbiome Clinical Trials

Cosmetic Effects of Topical Acetyl Zingerone

Start date: December 11, 2017
Phase: N/A
Study type: Interventional

Cosmeceuticals are an emerging market within dermatology and the growth of natural products and derivatives of natural products has accelerated in use within the field. Here the investigators aimed to study the microbial and cosmetic effects of Synoxyl AZ, the trade name for topical acetyl zingerone (AZ), a novel compound designed based on Zingerone and curcumin.

NCT ID: NCT03505879 Completed - Lyme Disease Clinical Trials

Next Generation Sequencing Detection of Lyme Disease

Start date: July 24, 2018
Phase:
Study type: Observational

Next Generation Sequencing is capable of sequencing millions of small strands of DNA from a single blood sample, potentially improving its sensitivity compared to PCR testing, which only detects predetermined larger strands of DNA. We will test the ability of NGS to detect Borrelia burgdorferi DNA in the blood of pediatric patients with Lyme disease. We will conduct an observational study of NGS testing on pediatric patients at all stages of Lyme disease. Study involvement will require a single study visit for clinical data collection and blood draw. We will enroll patients at all phases of suspected Lyme disease, collect clinically relevant information, and test for Lyme disease using Next Generation Sequencing and standard Lyme serologic testing. If the patient has multiple erythema migrans, Lyme meningitis, facial nerve palsy, arthritis, or carditis, a B. burgdorferi serum PCR will also be sent. Enrollment and Next Generation Sequencing blood draw will occur before or up to 24 hours after the first dose of antibiotics is administered. We will also study the impact of antibiotics on NGS testing by running the test 6-24 hours after antibiotics are started among a small subset of patients with a multiple erythema migrans rash. Collected data will be analyzed with basic descriptive statistics.

NCT ID: NCT03477825 Completed - Wrinkles Clinical Trials

Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin

Start date: March 12, 2018
Phase: N/A
Study type: Interventional

Few studies have assessed the effects of Triphala and Rubia Cordifolia from a skin biophysical perspective. Here, we aim to understand how these herbs can modulate the skin's barrier properties and the gut microbiome.

NCT ID: NCT03455036 Completed - Itch; Athlete Clinical Trials

The Mysterious on/Off Itch and Erythema During Whole Body Vibration Exercise

VIBRA
Start date: December 18, 2017
Phase: N/A
Study type: Interventional

Intense itch on the legs sometimes associated with redness can be adverse effects of whole body vibration (WBV) according to own observations and numerous posts in non-professional online-blogs. To the investigators' knowledge, the appearance of itch and/or a rash during WBV exercise has not yet been described. The research objectives are: 1. To determine the effect of WBV on itch rating and its unpleasantness and on skin changes. 2. To determine the effect of WBV on immunoglobulin E (IgE) and serum tryptase